D.A. Mitchison

St George's, University of London — United Kingdom

Medicine · Health Sciences

50h-index10.5kcitations193works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(145), Mycobacterium research and diagnosis(84), Pneumonia and Respiratory Infections(25), Pneumocystis jirovecii pneumonia detection and treatment(25), Antibiotics Pharmacokinetics and Efficacy(23)

Publications193 total

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
BMC Infectious Diseases·2016· 32 citedOpen Access
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis
The International Journal of Tuberculosis and Lung Disease·2016· 54 cited
Mechanisms of Pyrazinamide Action and Resistance
ASM Press eBooks·2015· 40 cited
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo
Frontiers in Microbiology·2015· 114 citedOpen Access
Hemagglutination Tests for Tuberculosis with Mycobacterial Glycolipid Antigens
American Review of Respiratory Disease·2015· 4 cited
Susceptibility Tests and Initial and Primary Drug Resistance in Tuberculosis
American Review of Respiratory Disease·2015
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model – A potential novel therapeutic target
Tuberculosis·2014· 17 cited
Mechanisms of Pyrazinamide Action and Resistance
Microbiology Spectrum·2014· 328 citedOpen Access
Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media
Journal of Antimicrobial Chemotherapy·2013· 65 citedOpen Access
Contradictory Results with High-Dosage Rifamycin in Mice and Humans
Antimicrobial Agents and Chemotherapy·2013· 11 citedOpen Access
The chemotherapy of tuberculosis: past, present and future [State of the art]
The International Journal of Tuberculosis and Lung Disease·2012· 186 cited
Optimizing Outpatient Serial Sputum Colony Counting for Studies of Tuberculosis Treatment in Resource-Poor Settings
Journal of Clinical Microbiology·2012· 21 citedOpen Access
Prevention of Drug Resistance by Combined Drug Treatment of Tuberculosis
Handbook of experimental pharmacology·2012· 28 cited
Chapter 5: Recent Developments in the Study of Pyrazinamide: An Update
Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research·2011· 4 cited
Activity of Pyrazinamide in the Guinea Pig Model of Tuberculosis
Antimicrobial Agents and Chemotherapy·2010· 1 citedOpen Access
Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
Tuberculosis·2010· 65 cited
Examining the Basis of Isoniazid Tolerance in Nonreplicating <i>Mycobacterium Tuberculosis</i> Using Transcriptional Profiling
Future Medicinal Chemistry·2010· 38 citedOpen Access
Effects of Four Different Meal Types on the Population Pharmacokinetics of Single-Dose Rifapentine in Healthy Male Volunteers
Antimicrobial Agents and Chemotherapy·2010· 43 citedOpen Access
The near future: Improving the activity of rifamycins and pyrazinamide
Tuberculosis·2010· 68 cited
Timing of relapse in short-course chemotherapy trials for tuberculosis.
PubMed·2010· 90 cited
page 1 of 10Next →

Frequent Co-authors

Anthony Coates(7), Jasvir Dhillon(6), Yanmin Hu(5), J.B. Selkon(5), B.W. Allen(4), Kath Sole(4), Jean M. Dickinson(4), Wallace Fox(3), G Canetti(2), H Mahler(2), Amina Jindani(2), Andrew Nunn(2), Philip D. Butcher(2), Juraj Iványi(2), John G. Wallace(2), Ankit Bhatia(2), T. V. Subbaiah(2), F A Sirgel(2), Joseph Odhiambo(2), C N Paramasivan(2)